Insulin stimulates glucose transport in fat and skeletal muscle cells primarily by inducing the translocation of GLUT4 (glucose transporter isoform 4) to the PM (plasma membrane) from specialized GSVs (GLUT4 storage vesicles). Glycosphingolipids are components of membrane microdomains and are involved in insulin-regulated glucose transport. Cellular glycosphingolipids decrease during adipocyte differentiation and have been suggested to be involved in adipocyte function. In the present study, we investigated the role of glycosphingolipids in regulating GLUT4 translocation. We decreased glycosphingolipids in 3T3-L1 adipocytes using glycosphingolipid synthesis inhibitors and investigated the effects on GLUT4 translocation using immunocytochemistry, preparation of PM sheets, isolation of GSVs and FRAP (fluorescence recovery after photobleaching) of GLUT4-GFP (green fluorescent protein) in intracellular structures. Glycosphingolipids were located in endosomal vesicles in pre-adipocytes and redistributed to the PM with decreased expression at day 2 after initiation of differentiation. In fully differentiated adipocytes, depletion of glycosphingolipids dramatically accelerated insulin-stimulated GLUT4 translocation. Although insulin-induced phosphorylation of IRS (insulin receptor substrate) and Akt remained intact in glycosphingolipiddepleted cells, both in vitro budding of GLUT4 vesicles and FRAP of GLUT4-GFP on GSVs were stimulated. Glycosphingolipid depletion also enhanced the insulin-induced translocation of VAMP2 (vesicle-associated membrane protein 2), but not the transferrin receptor or cellubrevin, indicating that the effect of glycosphingolipids was specific to VAMP2-positive GSVs. Our results strongly suggest that decreasing glycosphingolipid levels promotes the formation of GSVs and, thus, GLUT4 translocation. These studies provide a mechanistic basis for recent studies showing that inhibition of glycosphingolipid synthesis improves glycaemic control and enhances insulin sensitivity in animal models of Type 2 diabetes.
INTRODUCTION
Circulating hexoses enter mammalian cells through facilitative GLUTs (glucose transporters), which comprise a family of highly related 12 transmembrane-domain-containing proteins. Among the GLUT family, GLUT4 (GLUT isoform 4) is unique in that it is confined mainly to insulin-sensitive fat and muscle tissues, and is the major insulin-responsive GLUT isoform. Various aspects of this transporter, including its synthesis, intracellular storage and transport to/from the PM (plasma membrane), have been reviewed elsewhere [1] [2] [3] . In the basal state, GLUT4 resides mainly in a specialized intracellular compartment termed a GSV (GLUT4 storage vesicle). Insulin is known to stimulate IR (insulin receptor)-mediated signalling cascades that ultimately result in the recruitment of GLUT4 to the cell surface by dramatically accelerating GLUT4 insertion into the PM by exocytosis and inhibiting GLUT4 endocytosis, thereby increasing glucose flux into the cells. After insulin removal, GLUT4 rapidly internalizes from the PM, and is sequestered in the intracellular storage compartments. The decreased ability of insulin to stimulate translocation of GLUT4, or so-called insulin resistance, represents a primary defect in the development of Type 2 diabetes mellitus.
Little is known about the molecular mechanisms regulating the formation of various GSV pools, although some of the features and protein components of different pools have been described [4, 5] . In the present study, we have focused on the role of SLs (sphingolipids) in this process. In addition to being essential lipid constituents of mammalian cell membranes, accumulating evidence indicates that SLs are involved in the regulation of insulin signalling and GLUT4 trafficking [6] . First, elevated levels of SLs have been demonstrated in both diabetic humans and animal models of Type 2 diabetes [7] . Secondly, evidence from both in vitro studies and in vivo studies using G M3 -knockout mice have demonstrated that SLs act as negative regulators of insulin signalling [8] . Thirdly, sphingomyelinase (which releases ceramide from sphingomyelin) and short-chain ceramide itself inhibit PI3K (phosphoinositide 3-kinase) activation and insulinstimulated glucose uptake [9] .
In the present study, we have examined the possibility that changes in the overall level of SLs in 3T3-L1 adipocytes regulate GSV formation or translocation. This work was prompted by a previous study [10] and our own preliminary results showing a dramatic reduction in glycosphingolipids during differentiation of 3T3-L1 cells. Since addition of exogenous SLs has been shown to inhibit IR-mediated signalling, we decided to decrease SL levels in adipocytes by inhibiting de novo biosynthesis of SLs using various pharmacological inhibitors. We show that depleting glycosphingolipids (a subset of SLs) dramatically accelerated insulin-stimulated GLUT4 translocation without affecting insulin signalling. Further evidence from both in vitro budding of GLUT4 vesicles and the in vivo recovery of GSVs after photobleaching suggests that the formation of GSVs is altered by glycosphingolipid depletion and that the glycosphingolipid effect is specific for VAMP2 (vesicle-associated membrane protein 2)-positive GSVs. Thus our results provide evidence that SLs act as negative regulators of GSV formation.
EXPERIMENTAL Cell culture, adipocyte differentiation and electroporation
Murine 3T3-L1 pre-adipocytes were cultured in DMEM (Dulbecco's modified Eagle's medium) containing 25 mM glucose and 10 % (v/v) bovine calf serum. At 2 days postconfluence, differentiation into adipocytes was induced by changing the medium to DMEM containing 25 mM glucose, 10 % (v/v) fetal bovine serum, 1 μg/ml insulin, 0.5 μM dexamethasone and 0.5 mM 3-isobutyl-1-methylxanthine as described previously [11] . The maintenance medium was changed every 48 h. The cells were used between 8 and 12 days after differentiation. Full differentiation was confirmed when >95 % of the cells were positive after staining with 0.4 % Oil Red O.
3T3-L1 cells were transiently transfected by electroporation using an Amaxa Biosystems nucleoporator [12] . After electroporation of differentiated adipocytes, the cells were seeded on to collagen-coated glass coverslips placed in 35-mm-diameter dishes with complete medium and allowed to recover for 18-24 h.
Antibodies, inhibitors and miscellaneous reagents
Antibodies against GLUT4 (R&D Systems), Akt and phosphoAkt (Ser 472 /Ser 473 ) (BD Transduction), IRS (IR substrate)-1 and phospho-IRS-1 (Upstate), and VAMP2 and cellubrevin (Synaptic Systems) were from the indicated vendors. Fluorescent Alexa Fluor ® 594-labelled CtxB (cholera toxin B subunit) was from Invitrogen. FB1 (fumonisin B1) was from Sigma. NB-DGJ (N-butyldeoxygalactonojirimycin) was from Toronto Research Chemicals. P4 (D,L-threo-1-phenyl-2-hexadecanoylamino-3-pyrrolidinopropan-1-ol) and edo-P4 (D-threo-3P,4P-ethylenedioxy-P4) were generously provided by Dr James A. Shayman (Department of Internal Medicine, University of Michigan, Ann Arbor, MI, U.S.A.). The plasmid encoding the HA (haemagglutinin)-GLUT4-GFP (green fluorescent protein) was generously provided by Dr Samuel W. Cushman (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, U.S.A.). Unless otherwise indicated, all other reagents were from Sigma.
Lipid analysis and inhibitor treatments
Filipin staining of cholesterol, lipid extraction and TLC were performed as described previously [13] . SLs were separated by TLC and identified by comparison with known standards using chloroform/methanol/15 mM CaCl 2 (65:35:8, by vol.) as the developing solvent. Primulin or resorcinol was used as a detection reagent, and lipids were quantified by scanning densitometry [14] .
For inhibitor studies, pre-adipocytes on day 6 of differentiation were incubated with a general inhibitor of SL synthesis (20 μg/ml FB1) or with inhibitors of glycosphingolipid synthesis (100 μM NB-DGJ or 0.5 μM P4) for 4 days in culture to block de novo synthesis of SLs. For some studies, 0.1 μM edo-P4 [15] was used in place of P4, which was no longer available.
PM sheet assays
The PM lawn assay uses highly purified PM fragments on coverslips to allow measurement of the translocation of GLUT4 to the PM [16] . Briefly, at the conclusion of the indicated treatment, cells were rapidly washed in PBS, followed by a 30 s treatment in PBS containing 0.5 mg/ml poly-L-lysine. The cells were swollen by three rapid washes in hypotonic buffer, transferred to buffer B [70 mM KCl, 30 mM Hepes, 5 mM MgCl 2 and 3 mM EGTA (pH 7.4)] and sonicated using a probe sonicator to generate a lawn of PM fragments on glass coverslips. Samples were then fixed for 15 min using freshly prepared 2 % (w/v) paraformaldehyde, washed, incubated with various antibodies at 4
• C overnight, washed and incubated with fluorescently labelled secondary antibodies prior to fluorescence microscopy.
Subcellular membrane fractionation and immunoblotting
Fully differentiated adipocytes were subjected to a differential centrifugation procedure as described previously [17] . Briefly, cells were scraped and homogenized in ice-cold HES [20 mM Hepes, 1 mM EDTA and 255 mM sucrose (pH 7.4); 5 ml/10-cm-diameter plate] containing protease inhibitors [1 μg/ml pepstatin A, 0.2 mM di-isopropyl fluorophosphate, 20 μM L-transepoxysuccinyl-leucylamido-(4-guanidino)butane and 50 μM aprotinin]. The homogenate was centrifuged at 19 000 g for 20 min at 4
• C. The resulting pellet was resuspended in 2 ml of HES, layered on to 1 ml of 1.12 M sucrose in HES and centrifuged at 100 000 g for 1 h at 4
• C in a swingbucket rotor. PMs were collected from the interface by careful aspiration, resuspended in HES and collected by centrifugation at 41 000 g for 20 min at 4
• C. The supernatant from the 19 000 g spin was re-centrifuged at 41 000 g to yield an HDM (highdensity microsome) pellet, and the supernatant from this spin was centrifuged at 180 000 g for 75 min at 4
• C to collect LDMs (lowdensity microsomes). All fractions were resuspended in equal volumes of HES buffer (cell equivalents), snap-frozen in liquid nitrogen and stored at −80
• C prior to use. For detection of GLUT4, equal amounts of proteins were separated by SDS/PAGE on 10% (w/v) polyacrylamide gels, transferred on to PVDF membranes and detected using an anti-GLUT4 antibody. Protein content was determined with the BCA (bicinchoninic acid) kit (Pierce).
Phosphorylation of IRS and Akt
Fully differentiated adipocytes were serum-starved for 4-6 h and then treated with 100 nM insulin for 10 min at 37
• C. The cell lysates were then immunoblotted for IRS, phospho-IRS (Tyr 416 ), Akt and phospho-Akt.
In vitro GLUT4 vesicle budding assay
The in vitro GLUT4 vesicle budding assay was performed as described previously [5] . In brief, 3T3-L1 adipocytes were washed and homogenized as described above. The homogenate was centrifuged at 16 000 g for 20 min at 4
• C. The pellet (heavy membrane fraction) was washed twice with ice-cold budding buffer and resuspended in the same buffer. Washed heavy membrane fraction (250 μg/sample) was mixed with cytosol (500 μg) and supplied with an ATP regeneration system (1 mM ATP, 8 mM creatine phosphate and 1.5 units/ml creatine kinase) in a total volume of 250 μl. Samples were kept on ice for 5 min and transferred to 37
• C for 20 min. The samples were then centrifuged for a second time at 16 000 g for 20 min at 4
• C. The pellets of the second centrifugation (donor fraction) were removed and supernatants were centrifuged for 60 min at 200 000 g in a Beckman Type 42.2 Ti rotor to harvest de novo formed small vesicles. The vesicle fractions along with the donor fractions were analysed by Western blotting.
Fluorescence microscopy and immunofluorescence
Conventional fluorescence microscopy was carried out using an Olympus IX70 fluorescence microscope equipped with a Hamamatsu Orca100 CCD (charge-coupled device) camera (Hamamatsu Photonics Systems) and the Metamorph imageprocessing program (Universal Imaging). Confocal microscopy was carried out using a Zeiss model 510 microscope equipped with a ×100 (1.4 numerical aperture) objective. In any given experiment, all photomicrographs were exposed and processed identically for a given fluorophore. Intracellular fluorescence was quantified by analysing images of 20 cells or areas per experiment in at least three independent experiments per condition. Quantification of images was performed using Metamorph as described previously [18] . For these studies, wholecell fluorescence was determined by drawing borders around individual cells and the non-cellular background was subtracted.
For immunofluorescence staining of endogenous GLUT4 in differentiated 3T3-L1 cells, cells were serum-starved and then either unstimulated (control) or stimulated with insulin (100 nM) for 5 min at 37
• C, washed and fixed with 2 % formaldehyde for 20 min at room temperature (21 • C), followed by permeabilization with 0.05 % saponin for 2 min. Cells were then washed and quenched with 50 mM ammonium chloride. Samples were then blocked with 5 % (v/v) goat serum for 3 h at room temperature, followed by primary antibody staining overnight. The cells were then washed and incubated with secondary antibody for 45 min at room temperature in the dark, washed, mounted using SlowFade Gold (Invitrogen) and observed under the fluorescence microscope.
GLUT4 photobleaching assays
For photobleaching assays, 3T3-L1 cells were treated without or with P4 at day 6 of differentiation, transfected with HA-GLUT4-GFP after 3 days of P4 treatment, and processed for the photobleaching assay 24 h after transfection. Cells expressing HA-GLUT4-GFP were identified by fluorescence using an argon laser for excitation at 488 nm. Half of the extra-Golgi region of each transfected cell was highlighted using the LSM 510 software and then subjected to repetitive photobleaching of the delineated region using the 488 nm line of the argon laser at full power. Samples were maintained at 37
• C and images of the same cells were acquired (at low laser power) prior to bleaching, immediately after bleaching and every 2 min thereafter. The recovery of the extra-Golgi areas was then normalized to the unbleached Golgi area and quantified using the LSM 510 software.
RESULTS

Expression and distribution of glycosphingolipids during 3T3-L1 cell differentiation
Lane and co-workers [10] reported a loss of gangliosides upon differentiation of 3T3-L1 pre-adipocytes, suggesting that gangliosides might be involved in regulating the physiological function of adipocytes. To study this, we first examined the levels of G M3 ganglioside, the major glycosphingolipid in 3T3-L1 adipocytes, during the course of pre-adipocyte differentiation. 3T3-L1 pre-adipocytes were collected at different time points after initiation of differentiation, and SLs were extracted and analysed by TLC. As shown in Figure 1(a) , the G M3 content dramatically decreased at day 2, just prior to the massive induction of GLUT4 expression. We also examined the level and distribution of G M1 ganglioside using fluorescently labelled CtxB, which specifically binds to G M1 (Figure 1b) . Confocal microscopy showed that G M1 was mainly distributed in the perinuclear and punctate cytosolic structures in 3T3-L1 pre-adipocytes, and rapidly redistributed to the PM after 1 day of differentiation. The intensity of the CtxB staining decreased significantly during this redistribution, suggesting the loss of G M1 during differentiation.
Since glycosphingolipids decrease inversely with the increase in GLUT4 expression, we considered the possibility that a reduction in glycosphingolipids is necessary for proper localization and function of GLUT4. Thus we next compared the distribution of GLUT4 in undifferentiated and differentiated 3T3-L1 cells. Consistent with the literature [19] , little or no endogenous GLUT4 was detected in undifferentiated 3T3-L1 cells (Figure 1a) . However, when GLUT4 is heterologously expressed in undifferentiated 3T3-L1 cells, its localization in this context can be observed [20] . Accordingly, we expressed GLUT4-GFP in undifferentiated cells and found it was localized to perinuclear Golgi-like structures (see Supplementary Figure  S1 at http://www.BiochemJ.org/bj/427/bj4270143add.htm). Endogenous GLUT4 in differentiated 3T3-L1 adipocytes detected by immunofluorescence was localized to perinuclear and dispersed punctate structures, which is similar to previous studies describing GSVs in these cells [21] . GLUT4-GFP in undifferentiated 3T3-L1 cells showed no change in localization with insulin treatment, in contrast with endogenous GLUT4 in differentiated cells which was translocated in part to the PM (Supplementary Figure S1 ). These studies demonstrate that GLUT4 localization is different in undifferentiated 3T3-L1 cells (with high glycosphingolipids) from that in differentiated adipocytes (with lower glycosphingolipid content), but do not exclude the possibility that other factors (e.g. sortilin) are important for the localization of GLUT4 [20] .
SL depletion stimulates insulin-stimulated GLUT4 translocation
The decrease and redistribution of gangliosides before GSV formation during 3T3-L1 cell differentiation led us to hypothesize that SLs may be involved in the physiological functions of adipocytes, in particular in the acquisition of the insulin response. To test this hypothesis, we examined the insulin-induced GLUT4 translocation by modulating SL levels using various inhibitors of de novo SL synthesis. For these studies, 3T3-L1 cells after 6 days in differentiation medium were untreated (control) or treated for an additional 4 days with the ceramide synthase inhibitor FB1 [22] , or with glucosylceramide synthase inhibitors NB-DGJ [23] , P4 or edo-P4 [15] . These inhibitors depleted G M3 ganglioside levels by 50 -60 % relative to untreated control cells (Table 1) . Insulin stimulation (5 min) increased the level of GLUT4 on PM sheets 2.5-fold in control cells, whereas treatment with the SL inhibitors led to a 5-6-fold increase in GLUT4 at the PM relative to unstimulated cells (Figures 2a and 2b) . To ensure that the enhanced GLUT4 staining after the inhibitor treatments was not due to an altered accessibility of the anti-GLUT4 antibody to GLUT4 proteins, we examined the levels of GLUT4 after insulin stimulation in LDMs by Western blot analysis and again found an 
Table 1 Depletion of G M3 ganglioside levels in mature adipocytes after treatment with sphingolipid synthesis inhibitors
Adipocytes were differentiated for 6 days and then cultured with (or for controls, without) 20 μg/ml FB1, 0.1 μM edo-P4 or 100 μM NB-DGJ for an additional 4 days. Lipids were extracted and analysed by TLC and resorcinol staining (see the Experimental section). G M3 ganglioside spots from samples on chromatograms were identified by correspondence to standards and were quantified by image acquisition and analysis. Results increase in PM GLUT4 upon insulin stimulation in SL-inhibitortreated cells (Figures 2c and 2d) . Interestingly, this SL effect on GLUT4 translocation was most pronounced after 5 min of insulin stimulation, decreasing with prolonged insulin treatment. There was no significant difference in the PM GLUT4 levels after 30 min of insulin treatment compared with untreated cells (Figures 2e and  2f) . These results suggest that SL depletion affects the dynamics of insulin-stimulated GLUT4 translocation, but not the total amount of GLUT4 that is insulin-responsive. Since the same effects on GLUT4 translocation were seen with glycosphingolipid synthesis inhibitors (P4 and NB-DGJ) as with the general SL inhibitor FB1, we conclude that depletion of glycosphingolipids in particular is responsible for changes in GLUT4 transport.
Glycosphingolipid depletion had no effect on IR-mediated signalling
SLs, such as G M3 and ceramide, are reported to inhibit insulininduced IRS-1 activation and Akt activation respectively, and the subsequent trafficking of GLUT4 [9, 24] . We thus compared IR-mediated signalling in control cells and cells treated with FB1 to decrease all SLs, including ceramide and G M3 , or used cells treated with NB-DGJ to decrease only G M3 and the other glycosphingolipids. The whole-cell lysates were probed with different antibodies to detect total IRS-1 and Akt, or phosphorylated IRS-1 and Akt. We found that both FB1 and NB-DGJ treatment had little effect on IRS-1 and Akt phosphorylation relative to control cells (Figure 3 ). Thus the effects of SL depletion on GLUT4 translocation were not due to SL modulation of insulin signalling.
Enhanced GSV budding in SL-depleted cells
GLUT4 is predominantly found in small insulin-sensitive 60-70 S membrane vesicles, also called GSVs, which are believed to represent the major form of GLUT4 storage in adipocytes [20] . Previously, it has been found that entry of newly synthesized GLUT4 into GSVs is GGA [Golgi-localized, γ -ear-containing ARF (ADP-ribosylation factor)-binding protein]-dependent [24a] , suggesting that at least part of GSVs is derived from the TGN (trans-Golgi network) system. Since SLs are mainly synthesized at the Golgi [25] , we next examined whether GSV formation is altered in cells treated with inhibitors of SL synthesis. To test this hypothesis, we used the in vitro budding assay, established by Xu and Kandror [5] , which shows that isolated heavy (i.e. rapidly sedimenting) donor membranes from adipocytes can be used to reconstitute GLUT4 vesicle budding in a temperature-, ATP-and cytosol-dependent manner. As shown in Figure 4 (a), incubation of donor membranes with cytosol at 37 • C for 20 min resulted in the significant release of membrane vesicles containing GLUT4 and the transferrin receptor (lanes 2 and 3) . Pre-treatment with FB1 or P4 for 4 days caused a significant increase in the release of vesicles containing GLUT4 with little effect on transferrin receptor vesicles (FB1, lanes 4 and 5; P4, lanes 6 and 7). As a control, incubation of donor membranes with budding buffer (but not cytosol) did not cause any vesicle protein release (lane 1). Thus inhibiting de novo synthesis of SLs accelerates GSV formation.
Accelerated FRAP (fluorescence recovery after photobleaching) of GSVs in glycosphingolipid-depleted cells expressing GLUT4-GFP
To confirm the result in Figure 4(a) , we next examined the in vivo recovery of GSVs in cells transfected with GLUT4-GFP. Fully differentiated 3T3-L1 adipocytes were treated without or with P4 for 4 days and transfected with GLUT4-GFP. In both control and P4-treated cells, GLUT4-GFP was mainly distributed in perinuclear reticular structures and dispersed vesicular structures (GSVs) (Figure 4b ). We first photobleached half of the cellular area containing only dispersed vesicular structures, but not perinuclear structures, and then monitored the recovery of photobleached area every 2 min. The P4-pre-treated cells showed over 50 % recovery of GFP fluorescence 4 min after photobleaching, whereas for control cells the recovery was less than 20 % at 4 min. At each time point tested, we observed a significant acceleration of FRAP of GLUT4-GFP in SL-depleted cells compared with control cells (Figures 4b and 4c) . At 16 min after photobleaching, >80 % recovery of GLUT4-GFP was seen in P4-treated cells compared with 65 % recovery for control cells. These results indicate further that GSV formation is altered in SLdepleted cells.
Glycosphingolipid depletion enhances insulin-stimulated translocation of VAMP2, but not cellubrevin, to the PM At least two classes of GSVs have been characterized and distinguished by two vesicle-associated membrane v-SNARE (vesicular soluble N-ethylmaleimide-sensitive factor-attachment protein receptor) proteins: VAMP2 and cellubrevin, which are implicated in the insulin-regulated docking and fusion of GSVs with the PM [26] . There is evidence that VAMP2-positive GSVs represent the specialized GLUT4 storage pool that is rapidly responsive to insulin, whereas cellubrevin-positive GSVs exhibit a slow insulin response and are endosomally derived [27] . To distinguish which pool of GSVs was affected by SL depletion, we examined the insulin-stimulated translocation of VAMP2 and cellubrevin in 3T3-L1 adipocytes. Insulin stimulation induced an increase in both VAMP2 and cellubrevin at PM sheets in control adipocytes. P4 pre-treatment led to enhanced staining of VAMP2 proteins, but not cellubrevin or transferrin receptors in PM sheets ( Figure 5 ), suggesting that SL-depletion specifically regulates the formation of VAMP2-positive GSVs.
DISCUSSION
During 3T3-L1 adipocyte differentiation, the induction of GLUT4 expression and acquisition of the insulin response starts at day 3 of cell differentiation (Figure 1 ) [20] . Many proteins, such as PPAR-γ (peroxisome-proliferator-activated receptor-γ ) or C/EBP (CCAAT/enhancer-binding protein), have been reported to exhibit induced expression during adipocyte differentiation and are crucial for cell growth arrest and adipogenesis; others, such as GLUT4 and sortilin, are essential for the formation of GSVs and the insulin response [20] . In the case of lipids, neutral lipids (mainly triacylglycerols) start to accumulate within lipid droplets in adipocytes during differentiation and function as major energy depots. In contrast, as observed in the present study and reported previously [10] , G M3 and G M1 ganglioside content is dramatically decreased during differentiation. This loss and redistribution of glycosphingolipids immediately prior to the acquisition of the insulin response led us to speculate that glycosphingolipid reduction plays an important role in the formation of insulinresponsive GSVs. Using a series of biochemical inhibitors to deplete SLs in mature 3T3-L1 cells, we show in the present study that further reduction of glycosphingolipids in these cells accelerates the insulin-stimulated translocation of GLUT4 to the PM. We demonstrated that this increased translocation occurs in the absence of changes in insulin signalling. Finally, data from in vitro Golgi budding assays suggest that glycosphingolipid depletion may directly stimulate the formation of Golgi-derived (i.e. VAMP2-positive) GLUT4 vesicles from the Golgi apparatus. Our studies showing enhanced FRAP of GLUT4-GFP on dispersed vesicles in glycosphingolipid-depleted cells suggest that this depletion accelerates the formation and/or transport of GSVs.
The mechanisms by which glycosphingolipid depletion might accelerate the formation or translocation of GSVs are unknown at present. Since it is well known that glycosphingolipids and cholesterol interact in membrane microdomains [28] and that changes in SLs can influence cholesterol content and distribution [13, 29] , it is possible that glycosphingolipid depletion may act on GLUT4 distribution by affecting cholesterol, a known regulator of multiple vesicular processes [30] [31] [32] . However, filipin staining, a method used to detect cellular free cholesterol, showed no gross changes in fluorescence intensity or distribution in SL-depleted mature adipocytes compared with untreated controls (see Supplementary Figure  S2 at http://www.BiochemJ.org/bj/427/bj4270143add.htm). Thus it seems unlikely that glycosphingolipid depletion acts on GLUT4 distribution via changes in cholesterol. Rather, changes in glycosphingolipid composition may directly affect GSV formation by affecting the properties of the membranes (i.e. Golgi and transport vesicles) involved. This idea seems especially plausible because glycosphingolipids are synthesized in the Golgi [25] .
It has been shown that exogenous SLs, such as ceramide and G M3 , inhibit the IR-mediated response and insulin-stimulated GLUT4 translocation [8, 9] . In the present study, using multiple biochemical and cell biological approaches, we show that depleting glycosphingolipids dramatically accelerated insulinstimulated GLUT4 translocation to the PM and the formation of GLUT4-positive vesicles from the Golgi apparatus without affecting insulin signalling. Our data not only support the well-known negative regulation of insulin responsiveness by gangliosides (reviewed in [6, 7] ), but importantly may also explain the findings of others showing that inhibition of glycosphingolipid synthesis improves glycaemic control and enhances insulin sensitivity in animal models of Type 2 diabetes [33, 34] .
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